Search

Copyright of Family Medicine Forum / Forum Medycyny Rodzinnej is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Heart & Vascular Diseases / Choroby Serca & Naczyn is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The aim of the article is to summarize the current knowledge on the phenomenon of fear of hypoglycaemia and its impact on the metabolic control and well-being of the population of diabetic patients. The article proposes a description of clinical criteria useful for the diagnosis of the fear of hypoglycaemia in a non-normative and harmful form. Therapeutic directions are presented that have been proven effective in the recent years in reducing the level of maladaptive fear of hypoglycaemia, while also protecting the mental health of the patients. Despite extensive knowledge and numerous clinical trials undertaken in other countries, further research on diabetes-related anxiety disorders in Polish patients is needed. It is also advisable to create a database of culturally adapted management protocols for specialists that could increase the quali ty and effectiveness of the assistance provided in the outpatient health care. [ABSTRACT FROM AUTHOR]

The widespread use of personal insulin pumps in the treatment of type 1 diabetes has significantly improved the effects of therapy. Better metabolic control of diabetes, but also increased comfort of life and professional opportunities have been achieved. One of the functions that increased the effectiveness of insulin therapy using a personal insulin pump is the bolus calculator. The bolus calculator function allows the user to dose their insulin more accurately before meals and to correct hyperglycaemia. The bolus calculator algorithms in insulin pumps of individual manufacturers differ in the way they calculate the correction dose and the amount of so-called active insulin. Consequently, with the same treatment parameters, individual bolus calculators may offer a different dose of insulin. Understanding the principles of the bolus calculator by therapeutic team members and patients is very important for proper diabetes education and diabetes management. [ABSTRACT FROM AUTHOR]

Background. The aim of study was to evaluate clinical features in adults with metabolic syndrome at diagnosis of diabetes, depending on the exponents of absolute insulin deficiency. Material and methods. The study included 122 adults consecutively hospitalized in the Department of Internal Medicine and Diabetology in 2007-2010 who met the inclusion criteria: age under 50 years, newly diagnosed diabetes, the presence of metabolic syndrome. The study group was divided into two subgroups depending on the presence diabetic ketoacidosis. Results. Adults with the metabolic syndrome, with newly diagnosed diabetes and markers of absolute insulin deficiency, had at diagnosis significantly higher glycaemia (p = 0.009) and HbA1c (p = 0.001), and significantly lower C-peptide levels (p = 0.007) than that observed in the group without diabetic ketoacidosis. People with newly diagnosed diabetes with metabolic syndrome were generally classified as type 2 disease. The diagnosis that was significantly more often placed in the group without ketones (p = 0.002). However, regardless of the presence ketoacidosis, some patients were classified as type 2 diabetes or without specifying the type of diabetes. Study groups differed in the prevalence of ICA antibodies characteristic of type 1 diabetes (p = 0.005). Conclusions. Occurrence of ketoacidosis in adults with newly diagnosed diabetes and metabolic syndrome is not a prerequisite for the diagnosis of type 1 diabetes, nor the need for further treatment with insulin. In patients with newly diagnosed diabetes with ketoacidosis and a phenotype characteristic of type 2 diabetes to assess β cell function and autoantibodies may be useful when deciding how to treat. [ABSTRACT FROM AUTHOR]

Copyright of Experimental & Clinical Diabetology / Diabetologia Doswiadczalna i Kliniczna is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)